Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sedana Medical receives market approval in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted Sedana Medical AB (publ) marketing authorization for the company’s pharmaceutical product Sedaconda[®] (isoflurane) in the United Kingdom.This market approval will enable Sedana Medical to sell Sedaconda® (isoflurane) in the UK and to promote the clinical and health economic benefits of its therapy for inhaled sedation in intensive care. The medical device Sedaconda ACD has been sold in the UK for several years, and the company submitted the application for marketing authorization for Sedaconda® (isoflurane) in early

Finland launches a 20-qubit quantum computer – development towards more powerful quantum computers continues

Press release 10 October 2023 Today, VTT launched Finland’s second quantum computer – a 20-qubit superconductive device. The quantum computer is a result of intensive joint technology development between VTT and IQM Quantum Computers, demonstrating the companies’ excellence in developing technologies to scale up quantum computers.ESPOO, Finland (October 10th, 2023) VTT Technical Research Centre of Finland  and the European leader in building quantum computers, IQM Quantum Computers , have completed Finland's second quantum

Bravida increases energy efficiency at Huddinge Hospital with an order value of SEK 142 million

Bravida has been awarded a project by Locum to install ventilation, heating, electrical, automation and sprinkler systems in part of Huddinge Hospital. The technical upgrade will enable benefits such as an improved indoor climate for healthcare activities and reduced energy usage to be achieved.Bravida is carrying out the installations in the C2 building at Huddinge Hospital, which contains laboratory and specialised facilities utilised by the entire Region Stockholm; these have high demands, among other things, regarding ventilation and maintained operational reliability.“We are proud to

NCC to construct production facility in Denmark

NCC has been commissioned to construct a production facility in Denmark. The order value is approximately SEK 900 million.The production facility covers 70,000 square meters and NCC’s assignment consists of foundation engineering and the construction of a shell building with a concrete frame. The customer is undisclosed at this time. Foundation engineering work has commenced, and construction of the building will begin in late 2023. Completion of the project is expected at the end of 2025. The value of the foundation engineering assignment totals approximately SEK 50 million and was

Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology

Circio and Neoregen Biotech today announce the start of a research collaboration on novel circular RNA (circRNA) therapeutics based on Circio´s proprietary circVec technology. The parties will test the ability of Neoregen´s NICT (Neoregen Intra-Cellular delivery Technology) delivery system to enhance cellular uptake and nuclear transfer of circVec vectors compared to commercially available delivery technologies. circRNA is an emerging class of novel RNA-therapeutics that offers improved durability and enhanced protein expression compared to mRNA. Due to these potentially significant

Irisity's Operations in Israel Remain Unaffected Amidst Recent Terrorist Attacks.

Irisity AB (publ), a forefront AI video analytics provider, wishes to inform its stakeholders about the current state of its operations in the wake of the devastating terrorist attacks that occurred in Israel this past weekend. With its second largest office situated in Tel Aviv and a workforce of over thirty dedicated employees in the region, the safety and well-being of our team are paramount. The company unequivocally condemns these acts of violence and extends its heartfelt condolences to the victims, their loved ones, and all who have been adversely affected by these tragic events.

Nordea Bank Abp: Repurchase of own shares on 09.10.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares09.10.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 09.10.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |64,394 |10.26 |660,894.94

Join Chiquita in Making a ‘Small Change’ to Inspire a ‘Big Difference’ Through Sticker Series

Chiquita once again joins forces with American Cancer Society for Breast Cancer Awareness MonthFort Lauderdale, FL – October 9, 2023 – For the seventh year in a row, Chiquita is giving its iconic Blue Sticker a makeover in honor of National Breast Cancer Awareness Month. The new Pink Sticker, made to match the Pink Ribbon, an international symbol for breast cancer awareness, will adorn 200 million of Chiquita’s tasty yellow bananas worldwide. This small change, made in partnership with the American Cancer Society (ACS) , aims to help inspire women to make a big

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 09 October 2023 the Company bought 170,592 of its own shares for cancellation at a price of 207.780 pence per share.  The Company's issued ordinary share capital is 561,017,784 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 475,388,236. The above figure (475,388,236) may be used by shareholders as the denominator for the

Hansa Biopharma announces encouraging high-level results for first-in-human trial of HNSA-5487

HNSA-5487 is a next-generation IgG-cleaving enzyme and the lead candidate in the NiceR development programLund, Sweden, October 9, 2023. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced high-level results from NICE-01, the first-in-human trial for HNSA-5487. Results showed the molecule was safe and well tolerated. Fast and complete depletion of immunoglobulin G (IgG) antibodies was observed at increasing doses in all subjects. Pharmacokinetics (PK) was in line with expectations and pharmacodynamics (PD) (

#23-318 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#23-317 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Aino Hökeberg appointed as Kamux’s Chief Marketing and Concept Officer

Kamux Corporation, Stock Exchange Release, 9.10.2023 at 18:00 Aino Hökeberg appointed as Kamux’s Chief Marketing and Concept Officer Aino Hökeberg (40, M.Sc. Econ.) has been appointed as Kamux Corporation’s Chief Marketing and Concept Officer, responsible for marketing and business concept, and a member of the Group Management Team as of January 1, 2024. She will be based in Upplands Väsby, Sweden and report to CEO Tapio Pajuharju. Hökeberg joins Kamux from Fazer, where she has held various commercial positions since 2017, most recently as Director, eCommerce. Prior to Fazer, she

Issue of Equity

Acuity RM Group plc  ('ARM' or the 'Company') Issue of Equity and Total Voting Rights   Acuity RM Group plc (AIM:ACRM) announces the issue of 531,428 ordinary shares of 0.1 pence each (“Ordinary Shares”) to WH Ireland Limited in lieu of certain advisory fees.   Application has been made for a total of 531,428 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will be effective from 13 October 2023. Following Admission, the Company's issued share capital will consist of 121,556,731 Ordinary Shares of which no shares are held in

What’s Going on in the Gambling Market?

In 2023, there have been many changes in the gambling market: the year was marked by new gambling regulations, the revival of some markets after COVID-19, and market repositioning.Slotegrator, one of the industry’s leading software and business solution providers for online casino and sportsbook operators, visited markets where the company has partners and customers. This has given the company a clear perception of the real market situation in Europe, Latin America, Asia and Africa. Let's take a first-hand look at Slotegrator’s key conclusions of the year.  Europe Europe is an

CEO Torsten Freltoft presents AcouSort's opportunities in cell therapy and diagnostics at LSX Nordic Congress on October 10

AcouSort is an innovative medical technology company developing critical components for instrumentation used in the diagnostics, analytics, and cell therapy processing markets. The company is in early commercial phase with continuously strengthened positions in the company's focus areas – diagnostics, cell therapy and innovation.The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the

Cabonline receives approval from the noteholders in the written procedure for its outstanding notes

On 20 September 2023, Cabonline Group Holding AB (publ) (the “Company” or “Cabonline”) initiated a written procedure (the “Written Procedure”) under its existing SEK 1,650,000,000 senior secured sustainability-linked floating rate notes with ISIN SE0017767346 (the “Notes” and each holder of Notes, a “Noteholder”). The Written Procedure was initiated for the purpose of requesting the Noteholders’ approval of the implementation of the Transaction as summarised and defined in the Company’s press release dated 20 September 2023 and as further set out in the notice of Written Procedure which is

ParkMobile to Modernize Parking in the City of Cleveland, Ohio

Drivers will soon be able to pay for parking in downtown Cleveland via ParkMobile's mobile app or web browserCleveland, Ohio – October 9, 2023 — ParkMobile , the leading provider of smart parking and mobility solutions in North America and part of EasyPark Group , will soon be modernizing parking in Cleveland, Ohio. In late October, the ParkMobile app will be available for on-demand parking throughout downtown Cleveland as part of a partnership with the City. Once launched, users can pay for parking digitally via ParkMobile by entering the

John Mattson sells property in Högdalen

John Mattson has signed an agreement today for the sale of the Trappsteget 2 property in Högdalen. The price is based on an underlying property value of SEK 236 million before deduction for latent tax. The buyer is Arne Dufva Högdalen AB.The Trappsteget 2 property is located in the Högdalen district of Stockholm and comprises 72 apartments. The total lettable area amounts to 4,447 square metres, all of which is residential. The price is based on an underlying property value of SEK 236 million before deduction for latent tax, which is SEK 4 million below the property’s carrying amount as of

Valo, a New Christian Dating App, Focuses on Finding a Relationship instead of Casual Dating

HELSINKI, Oct. 10, 2023 – In today `s fast-paced world of online dating, where options seem endless and choices overwhelming, Valo is proud to announce a groundbreaking approach to redefine the dating landscape. Recognizing the emerging trend of accumulating matches without genuine intent, Valo introduces a unique concept designed to foster meaningful connections and overcome the ”matching paradox”.   The dating scene has witnessed a curious phenomenon – individuals gathering matches like tokens of validation, akin to curating a partner "farm.” This behavior, although initially

Delisting of BuildData Group AB

Nasdaq Stockholm has decided that BuildData Group AB will be delisted from Nasdaq First North Growth Market. The last day of trading will be on Friday, October 20, 2023.For more information, please contact: Gustave Geisendorf, CEO in BuildData Group AB Tel: +44 7760 760 777 E-mail: gustave.geisendorf@builddata.se About BuildData Group AB BuildData Group AB is a cloud-based construction management software company. The Group’s operations are conducted in Ireland with operations in the UK, Australia and the Middle East. The Company is listed on Nasdaq First North Growth

There are no items matching the current filter
There are no more items matching the current filter
Back to top